Development of an immunoassay for a quaternary ammonium compound, benzyldimethyldodecylammonium chloride
摘要:
A competitive enzyme-linked immunosorbent assay (CELISA), based on polyclonal antibodies, was developed to measure benzyldimethyldodecylammonium chloride (BDD(12)AC), a component of benzalkonium chloride (BAK). The polyclonal antibodies recognized free benzyldimethyldodecylammonium bromide (BDD(12)AB) in an indirect competitive ELISA with a 50% inhibition (IC50) of 0.66 +/- 0.20 mu g/ml and a detection limit of 0.043 +/- 0.033 mu g/ml. The two other components of BAK, benzyldimethyltetradecylammonium chloride (BDT(14)AC) and benzyldimethylhexadecylammonium chloride (BDH(16)AC), were recognized to varying degrees by the antibodies. The antibodies did not cross-react with other compounds such as fatty acids and alcohols, amino acids, amines, and short-chain quaternary ammonium compounds. Cross-reactivity was observed with other alkyldimethylbenzylammonium compounds (ADBACs). The CELISA and HPLC were used to measure the amount of pure BDD(12)AB spikes in milk and BDD(12)AC in five commercial products. HPLC analysis correlated well with CELISA analysis for spiked samples. (C) 1998 Elsevier Science Ltd. All rights reserved.
High-Throughput Screening of Reductive Amination Reactions Using Desorption Electrospray Ionization Mass Spectrometry
作者:David L. Logsdon、Yangjie Li、Tiago Jose Paschoal Sobreira、Christina R. Ferreira、David H. Thompson、R. Graham Cooks
DOI:10.1021/acs.oprd.0c00230
日期:2020.9.18
screening system that is capable of screening thousands of organicreactions in a single day. This system combines a liquid handling robot with desorption electrospray ionization (DESI) mass spectrometry (MS) for a rapid reaction mixture preparation, accelerated synthesis, and automated MS analysis. A total of 3840 unique reductive amination reactions were screened to demonstrate the throughputs that are
암모니아보레인과 외부 자력으로 고정된 자성 나노촉매를 이용한 연속 니트로 환원 반응과 환원적 아민화 반응
申请人:Pusan National University Industry-University Cooperation Foundation 부산대학교 산학협력단(220040044843) BRN ▼621-82-06530
公开号:KR20190040415A
公开(公告)日:2019-04-18
본 발명은 자성 촉매와 니트로 화합물 및 환원제를 연속적으로 접촉시켜 니트로 화합물을 환원시키고, 여기에 알데히드 화합물을 연속적으로 공급하여 환원적 아민화 반응시켜 2차 아민 화합물을 연속적으로 생성시키는 것을 포함하는, 니트로 화합물의 연속 환원 방법, 및 이를 위한 장치를 제공하는 것이다.
COMPOSITION FOR FORMING RESIST UNDERLAYER FILM AND PATTERNING PROCESS
申请人:SHIN-ETSU CHEMICAL CO., LTD.
公开号:US20140235796A1
公开(公告)日:2014-08-21
The invention provides a composition for forming a resist underlayer film including: as a component (A), a silicon-containing compound obtained by hydrolysis and/or condensation of one or more kinds of silicon compounds represented by the following general formula (A-1). There can be provided a composition for forming a resist underlayer film having etching selectivity relative to a conventional organic film and a silicon-containing film and favorable pattern adhesiveness relative to fine pattern even in a complicated patterning process.
R
1A
a1
R
2A
a2
R
3A
a3
Si(OR
0A
)
(4-a1-a2-a3)
(A-1)
N-Benzyl-N-methyl-dodecan-1-amine, a novel compound from garlic, exerts anti-cancer effects on human A549 lung cancer cells overexpressing cancer upregulated gene (CUG)2
作者:Sirichat Kaowinn、Chutima Kaewpiboon、Ji Eun Kim、Mi Rim Lee、Dae Youn Hwang、Young Whan Choi、Hong Won Kim、Jin Kyoon Park、Kyung-Mo Song、Nam Hyouck Lee、Jin-Soo Maeng、Young-Hwa Chung
DOI:10.1016/j.ejphar.2018.09.035
日期:2018.12
Dietary garlic has been suggested to possess anticancer properties, and several attempts have been made to isolate the anticancer compounds. In this study, we efficiently synthesized N-benzyl-N-methyl-dodecan-1-amine (BMDA) by the reductive amination method. We evaluated the potential anticancer activities of BMDA against A549 lung cancer cells with cancer stem cell-like phenotypes due to the overexpression of cancer upregulated gene (CUG)2. N-Benzyl-N-methyl-dodecan-1-amine treatment sensitized A549 cells overexpressing CUG2 (A549-CUG2) to apoptosis and autophagy compared with those of the control cells. The treatment with BMDA also reduced tumor development in xenografted nude mice. Furthermore, BMDA inhibited cell migration, invasion, and sphere formation in A549-CUG2 cells, in which TGF-beta signaling is involved. Further analysis showed that BMDA hindered TGF-beta promoter activity, protein synthesis, and phosphorylation of Smad2, thus decreasing the expression of TGF-5-targeted proteins, including Snail and Twist. N-Benzyl-N-methyl-dodecan-1-amine also decreased Twist expression in vivo. In addition, BMDA inhibited Akt-ERK activities, beta-catenin expression, and its transcriptional activity. These results suggest that BMDA can be a promising anticancer agent against cancer cells overexpressing CUG2.
HAYASHI, YOSHIYUKI;FUJIWARA, TSUYOSHI;SHIMIZU, TOMIO;NAGANO, YOSHIO;TERAM+, J. JAP. OIL CHEM. SOC., 36,(1987) N 6, 409-412